Antibe Therapeutics Inc. announced that Walt Macnee has been appointed as Chairman of the Board of Directors of the Corporation to replace John Wallace, who will continue to serve as a director and Chief Science Officer. Mr. Macnee's appointment was made to ensure that the Chairman position is occupied by an independent director. Antibe thanks Dr. Wallace for his past services as Chairman.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 CAD | -.--% | -.--% | -68.28% |
Apr. 24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
Apr. 19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.28% | 11.49M | |
+7.84% | 115B | |
+12.87% | 107B | |
-13.54% | 22.31B | |
-3.99% | 21.6B | |
-6.35% | 18.23B | |
-39.93% | 17.62B | |
+7.00% | 14.26B | |
+33.11% | 12.37B | |
-28.12% | 8.28B |
- Stock Market
- Equities
- ATE Stock
- News Antibe Therapeutics Inc.
- Antibe Therapeutics Inc. Announces Board Changes